Report Summary 1. Reported Industry Investment Rating No information provided in the document. 2. Core Viewpoints The report mainly presents the results of a research on Xinhan New Materials, covering the company's basic information, research institutions, and answers to investors' questions about the company's operations, including project progress, cash management, product sales, investment purposes, R & D directions, and the impact of trade protection measures [16][23][28]. 3. Summary by Directory 3.1 Research Basic Situation - Research object: Xinhan New Materials [16] - Industry: Chemical raw materials [16] - Reception time: September 12, 2025 [16] - Listed company reception personnel: Chairman and General Manager Yan Liuxin, Financial Controller Wang Zhongyan, Board Secretary Li Xiangfei, Independent Director Huang Hefa [16] 3.2 Detailed Research Institutions - Institutions: Investors who participated in the company's 2025 semi - annual performance briefing online [19] 3.3 Main Content Data - **Project Progress**: The equipment of the third workshop of the 8000 - ton project is being installed and is expected to reach the intended use state and be put into production in December 2025 [23] - **Cash Management**: The company's cash management is mainly used to purchase cash management products with high safety, good liquidity, and a maximum term of no more than twelve months, such as RMB structured deposits and time deposits [24] - **Foreign Exchange Hedging**: The company did not actually carry out specific foreign exchange hedging business during the reporting period and plans to conduct it within the board - authorized limit according to exchange rate fluctuations [26] - **Product Sales**: The sales of the company's main products such as medical and agricultural intermediates, DFBP, and photoinitiators have all increased to varying degrees [27] - **Investment Purpose**: The company invests in Mingxi Equity Investment Fund and Zhejiang Pengfulong Technology to layout fields related to its main business, achieve industrial synergy and capital appreciation, and strengthen its influence in the special engineering plastics field [28] - **R & D Direction**: The company's main R & D direction is focused on the R & D and process improvement of aromatic ketone core products, including special engineering plastic core raw materials and cosmetic raw materials [28] - **Product Situation**: The penetration rate of the company's HAP product as a cosmetic raw material is gradually increasing, and the HDO production line is under construction. The HDO product can be directly used as a cosmetic raw material with moisturizing and bactericidal effects [30] - **Trade Protection Impact**: The company will closely monitor international market trends, actively explore new international markets, develop new products, and expand the domestic market to reduce the impact of export business risks [30] - **Medical and Agricultural Intermediate Business**: The company's medical and agricultural intermediate products have a large variety. After the new workshop of the 8000 - ton project is put into operation, new customers and markets are developed, resulting in rapid growth [30]

Group 1: Company Operations and Developments - The construction of the third workshop for the 8000-ton project is currently underway, with equipment installation in progress and expected to be operational by December 2025 [2] - The company is focusing its cash management on high-security, high-liquidity products, including structured deposits and time deposits, with a maximum term of twelve months [2] - The company has not yet implemented specific foreign exchange hedging activities but is monitoring exchange rate fluctuations closely [3] Group 2: Product Performance and Market Strategy - Sales of key products such as pharmaceutical intermediates, DFBP, and photoinitiators have shown varying degrees of growth [3] - Investments in Mingxi Equity Investment Fund and Zhejiang Pengfulong Technology aim to enhance synergy with the company's main business and strengthen its influence in the specialty engineering plastics sector [3] - The company is concentrating its R&D efforts on core products related to aromatic ketones and process improvements, with specific advancements to be disclosed in the annual report [3] Group 3: Market Challenges and Adaptations - The company is actively exploring new international markets to mitigate risks associated with U.S. tariffs and trade protection measures affecting exports [4] - The pharmaceutical intermediates segment is expected to become a significant growth driver following the new workshop's production capacity expansion [4]

1. Report Industry Investment Rating - No information provided in the given content. 2. Report's Core View - In the first half of 2025, the company achieved an operating income of 229 million yuan, a year - on - year increase of 9.66%, and a net profit of 35.29 million yuan, a year - on - year increase of 20.40%. The company is optimistic about the development of the PEEK industry chain, and the market prospects of HAP and HDO in cosmetics raw materials are good. The company's product sales volume and gross profit margin have increased, mainly due to capacity improvement [24]. 3. Summary According to Relevant Catalogs 3.1 Research Basic Situation - Research object: New Han New Materials; Industry: Chemical raw materials; Reception time: August 26, 2025; Listed company reception personnel: Board Secretary Li Xiangfei, Securities Affairs Representative Ge Mingmin, and Financial Controller Wang Zhongyan [16]. 3.2 Detailed Research Institutions - Fund management companies: Harvest Fund (represented by Xu Heyang), Donghai Fund (represented by Zhang Yuantao), CITIC Prudential Fund (represented by Yao Sizhou), Jianxin Fund (represented by Wu Angda), Chunhou Fund (represented by Tian Wentian) [17]. - Investment companies: Shanghai Xishirun Investment (represented by Liu Chongli), Bissell (Shanghai) Investment (represented by Luo Hongyong), Shanghai Jisheng Investment (represented by Liu Qinglin) [17]. - Securities companies: Nanjing Securities (represented by Gu Shiyuan), Shenwan Hongyuan (represented by Li Shaocheng) [17]. - Others: Zhengyuan Private Fund (represented by Liu Jiasuo) [17]. 3.3 Main Content Data - **2025 Semi - annual Brief Analysis**: The company's operating income in the first half of 2025 was 229 million yuan, a year - on - year increase of 9.66%, and the net profit was 35.29 million yuan, a year - on - year increase of 20.40%. The comprehensive gross profit margin and sales net profit margin improved for two consecutive quarters, reaching 27% and 15.41% respectively. The sales volume of the company's main products increased by about 30%, among which the sales volume of DFBP, HAP, and photoinitiators increased by about 25%, and the sales volume of medical and agricultural intermediates increased by more than 50% [24]. - **Question and Answer Session**: - **DFBP sales growth reason**: Due to the continuous exploration of new application fields of PEEK, the number of new customers of PEEK has increased in the past two years. The company has maintained stable cooperation with old customers, and the orders of individual new customers have also increased [24]. - **PEEK industry prospects**: PEEK has excellent comprehensive performance, and its new attempts in fields such as aerospace, human implants, high - end manufacturing, low - altitude aircraft, and robots have added new growth momentum to the market. The company is optimistic about the development of the PEEK industry chain [24][25]. - **Market prospects of HAP and HDO in 2025**: The company's HAP product is mainly used in high - end creams and masks of well - known brands, and the use cases of some new cosmetic categories and new domestic and foreign brands are increasing. The HDO product can be directly used as a cosmetic raw material, with good moisturizing and bactericidal effects, and is used as a new type of preservative additive similar to HAP, targeting the same customer group as HAP [25]. - **Reason for the increase in the sales volume of pharmaceutical intermediates in the first half of 2025**: After the new workshop of the 8,000 - ton project was put into production, the company's production capacity was sufficient to support the development of new customers and markets for this type of product [26]. - **Factors for the recovery of the company's product gross profit margin in the first half of the year**: The main reason is the stable increase in the company's capacity utilization rate, and the fixed cost per unit product has decreased [26].

Core Insights - The company reported strong revenue and profit growth in the first half of 2025, driven by increasing demand for PEEK materials and a robust performance across its four main business segments [1][2][3] Business Performance - The company achieved a revenue of 229 million yuan, a year-on-year increase of 9.66%, and a net profit of 35.29 million yuan, up 20.40% [2] - The core specialty engineering plastics segment generated revenue of 97.03 million yuan, reflecting a growth of 5.54%, with a gross profit margin of 32.3%, an increase of 7.61 percentage points [2][3] - The light initiators and agricultural intermediates businesses also performed well, with revenues of 38.36 million yuan and 46.39 million yuan, representing year-on-year growth of 11.94% and 38.73%, respectively [3][4] Market Trends - The demand for PEEK materials is expected to grow significantly, with projections indicating an increase from 2,334 tons in 2022 to 5,079 tons by 2027, corresponding to a compound annual growth rate of approximately 16.8% [3] - The company has established stable partnerships with key clients in the PEEK industry, enhancing its competitive position [3] Technological Innovation - The company emphasizes technological innovation as a core driver of its sustained growth, holding 29 invention patents and 21 utility model patents [6][7] - The company has been recognized as a high-tech enterprise and has received various industry accolades, reinforcing its market credibility [6] Production Capacity and Environmental Focus - The company is expanding its production capacity with a new annual capacity of 2,500 tons of DFBP, which will enhance its market competitiveness [3][7] - The company is committed to green manufacturing and has implemented new technologies to reduce emissions and improve production efficiency [7] Shareholder Returns - The company plans to distribute cash dividends of 1.00 yuan per 10 shares to shareholders, reflecting its commitment to shareholder returns and strong profitability [4]

Financial Performance - The company achieved a revenue of 229 million yuan in the first half of 2025, representing a year-on-year increase of 9.66% [2] - Net profit reached 35.29 million yuan, showing a growth of 20.40% compared to the previous year [2] - The overall gross profit margin improved to 27%, while the net profit margin increased to 15.41% [2] - Sales volume of main products increased by approximately 30%, with DFBP, HAP, and photoinitiators rising by around 25%, and pharmaceutical intermediates sales increasing by over 50% [2] Product Insights - DFBP sales growth is attributed to both increased orders from existing customers and new customer acquisitions [3] - PEEK's market outlook is positive due to its excellent performance characteristics, with applications expanding in aerospace, medical implants, and high-end manufacturing [4] - HAP is increasingly used in mid-to-high-end cosmetic products, with a growing number of new brands adopting it [4] - HDO serves as a cosmetic raw material with moisturizing and antibacterial properties, targeting the same customer base as HAP [4] Capacity and Cost Management - The increase in sales of pharmaceutical intermediates is linked to the new 8000-ton project that has expanded production capacity, allowing for new customer acquisition [5] - The recovery in gross profit margin is primarily due to stable capacity utilization and a decrease in fixed costs per unit of product [5]

Group 1 - The core viewpoint of the news is that Panjing Investment has conducted research on a listed company, focusing on the DFBP industry, production capacity, sales growth, and future market prospects [1] - DFBP is primarily used for PEEK polymerization and has limited domestic large-scale production manufacturers; the company has added 2500 tons of production capacity which is now in bulk supply [1] - The production barriers for DFBP are related to quality affecting PEEK performance, requiring long-term technical accumulation [1] Group 2 - The revenue and profit growth in Q1 is attributed to increased sales volume and improved gross margin [1] - The expected decline in gross margin for 2024 is due to intensified competition leading to price reductions and increased fixed costs from ramping up production capacity [1] - The market demand for HDO is anticipated to exceed that of HAP, with the company planning to optimize production structure and adjust capacity according to market demand [1]

Group 1: DFBP Industry Overview - DFBP is primarily used in the polymerization of PEEK, which has applications in electronics, transportation, aerospace, energy, healthcare, and 3D printing [2] - The supply of DFBP is limited, with major production concentrated in China, and the company is currently the largest domestic producer [3] Group 2: Production Capacity and Utilization - The company has added 2,500 tons of DFBP capacity, which has been validated by both domestic and overseas PEEK manufacturers [3] - Current capacity utilization rates for HAP and DFBP are steadily increasing, with ongoing construction of the second phase of the project [4] Group 3: Market Dynamics and Pricing - Product prices will be adjusted based on raw material costs and market competition, with expected fluctuations in 2025 [4] - In Q1 2025, the company experienced a significant increase in sales volume, leading to higher revenue compared to the previous year [5] Group 4: Profit Margins and Competitive Strategy - The decline in product gross margin in 2024 is attributed to competitive pricing strategies and increased fixed costs per unit due to production ramp-up [5] - The company is focusing on flexible production capacity adjustments to optimize product offerings and enhance profitability [5] Group 5: Future Product Development - HAP is used in high-end cosmetics, with new brands beginning to adopt the product, while HDO is expected to have a larger market demand due to its versatile applications [5] - The company plans to optimize the production structure of its aromatic ketone products and adjust capacity based on market demand [5]

Financial Performance - In 2024, the company achieved a revenue of 419 million CNY, with a net profit of 55.97 million CNY [2] - In Q1 2025, the revenue was 116 million CNY, and the net profit reached 16.19 million CNY [3] - Revenue in 2024 decreased by 3.66% compared to the previous year, primarily due to a reduction in product sales prices, despite a 30% increase in total sales volume [3] - In Q1 2025, revenue increased by 12.43% year-on-year, with sales volume across major product categories rising by over 30% [3] Product Performance - Sales of specialty engineering plastics remained stable, while sales of photoinitiators increased by nearly 30% [3] - Cosmetic raw material sales doubled, and sales of agricultural and pharmaceutical intermediates increased by over 40% [3] - DFBP sales volume in Q1 2025 increased by approximately 30% compared to the same period last year [5] Market Outlook and Strategy - The company plans to enhance market expansion efforts and improve capacity utilization [7] - The HAP product is primarily used in high-end skincare products, with new brands starting to adopt it [7] - HDO products serve as cosmetic raw materials with good moisture retention and antibacterial properties, targeting the same customer base as HAP [7] - The company aims to explore new growth points in specialty engineering plastics and cosmetic raw materials [7] Cost and Pricing Dynamics - Product prices will be adjusted based on raw material costs and market competition [6] - An increase in capacity utilization is expected to lower fixed costs per unit, leading to a recovery in gross profit margins in Q1 2025 [6]

Company Overview - The company specializes in the research, production, and sales of aromatic ketone products, including core raw materials for specialty engineering plastics, photoinitiators, and cosmetic raw materials [2] - The company has established stable partnerships with major global manufacturers in the PEEK (Polyether Ether Ketone) industry, such as VICTREX, SYENSQO, and EVONIK [11] Industry Situation Specialty Engineering Plastics - PEEK - PEEK is a high-performance thermoplastic with excellent properties such as high heat resistance, radiation resistance, and chemical stability, making it a popular choice in various industries [4] - The demand for PEEK in China is expected to grow significantly, with production projected to reach approximately 3,809 tons and demand around 3,894 tons by 2024, reflecting a rapid expansion trend [5] - The global PEEK market is forecasted to reach 6.1 billion yuan by 2024 and 8.54 billion yuan by 2027, with a compound annual growth rate (CAGR) of 13.7% in the Chinese market from 2022 to 2027 [5][6] Photoinitiators - Photoinitiators are essential components in photopolymerization processes, which are increasingly replacing traditional solvent-based materials due to their efficiency and environmental benefits [11] - The market for UV coatings, inks, and adhesives in China is projected to grow, with the UV ink market being the largest application area, driven by the PCB industry [12] Cosmetic Raw Materials - The market for cosmetic preservatives is expected to reach 1.4 billion USD by 2024, with a growing demand for new, safer preservatives due to regulatory changes and consumer preferences [16] - The company's HAP and HDO products are recognized for their multifunctional properties, including antioxidant and antimicrobial effects, making them suitable alternatives to traditional preservatives [15][19] Key Performance Drivers - The company benefits from supportive national policies and technological advancements in the fine chemical industry, which are crucial for sustainable development [20][22] - The increasing demand for high-performance materials in various sectors, including aerospace, automotive, and healthcare, is driving the growth of the PEEK market [20][21] - The company's established reputation and partnerships with high-end clients in specialty engineering plastics, photoinitiators, and cosmetic raw materials enhance its competitive position [22]